RELT and cancer: TNFRSF19L is a new member of the tumor necrosis factor receptor superfamily, and is upregulated when tumor cells undergo the epithelial‐mesenchymal transition critical for cancer development.12 However, TNFRSF19L was found to be elevated in gastric cancer for the first time in this study.